期刊
CANCER LETTERS
卷 357, 期 1, 页码 55-62出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2014.11.037
关键词
Stem cell factor; SALL4; Cancer; Biomarker; Target
类别
资金
- Major Research Plan of the National Natural Science Foundation of China [91129718]
- National Natural Science Foundation of China [81201660]
- Natural Science Foundation of the Jiangsu Province [BK2012709, BK20141303]
- Jiangsu Province's Project of Scientific and Technological Innovation and Achievements Transformation [BL2012055]
- Jiangsu Province's Outstanding Medical Academic Leader and Sci-tech Innovation Team Program [LJ201117]
- Jiangsu Province's Qing Lan project
- Foundation for Young Academic Leader of Jiangsu University
- Starting Foundation for Senior Talents of Jiangsu University [13JDG086]
SALL4 is a transcription factor that plays essential roles in maintaining self-renewal and pluripotency of embryonic stem cells (ESCs). In fully differentiated cells, SALL4 expression is down-regulated or silenced. Accumulating evidence suggest that SALL4 expression is reactivated in cancer. Constitutive expression of SALL4 transgene readily induces acute myeloid leukemia (AML) development in mice. Gain- and loss-of-function studies reveal that SALL4 regulates proliferation, apoptosis, invasive migration, chemoresistance, and the maintenance of cancer stem cells (CSCs). SALL4 controls the expression of its downstream genes through both genetic and epigenetic mechanisms. High level of SALL4 expression is detected in cancer patients, which predicts adverse progression and poor outcome. Moreover, targeted inhibition of SALL4 has shown efficient therapeutic effects on cancer. We have summarized the recent advances in the biology of SALL4 with a focus on its role in cancer. Further study of the oncogenic functions of SALL4 and the underlying molecular mechanisms will shed light on cancer biology and provide new implications for cancer diagnostics and therapy. (c) 2014 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据